Rf
1 product
1 abstract
Abstract
Phase II study of the efficacy of retifanlimab (Rf) (INCMGA00012) in penile squamous cell carcinoma (PSqCC): ORPHEUS final analysis.Org: Medical Oncology Group, Institut Català d'Oncologia (ICO) L ́Hospitalet and Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy, Hospital Universitario 12 de Octubre (CIBERONC), IRCCS Ospedale San Raffaele,
Product
rF1V